- Home
- EIG vs TVTX Comparison
EIG vs TVTX Comparison
Compare EIG & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIG
- TVTX
- Stock Information
- Founded
- EIG 2000
- TVTX 2008
- Country
- EIG United States
- TVTX United States
- Employees
- EIG N/A
- TVTX N/A
- Industry
- EIG Property-Casualty Insurers
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EIG Finance
- TVTX Health Care
- Exchange
- EIG Nasdaq
- TVTX Nasdaq
- Market Cap
- EIG 1.3B
- TVTX 1.3B
- IPO Year
- EIG 2007
- TVTX N/A
- Fundamental
- Price
- EIG $53.23
- TVTX $18.25
- Analyst Decision
- EIG Strong Buy
- TVTX Buy
- Analyst Count
- EIG 1
- TVTX 13
- Target Price
- EIG $58.00
- TVTX $23.46
- AVG Volume (30 Days)
- EIG 120.3K
- TVTX 1.4M
- Earning Date
- EIG 10-30-2024
- TVTX 10-31-2024
- Dividend Yield
- EIG 2.25%
- TVTX N/A
- EPS Growth
- EIG 20.58
- TVTX N/A
- EPS
- EIG 5.34
- TVTX N/A
- Revenue
- EIG $889,800,000.00
- TVTX $203,447,000.00
- Revenue This Year
- EIG N/A
- TVTX $62.45
- Revenue Next Year
- EIG $1.03
- TVTX $59.30
- P/E Ratio
- EIG $9.97
- TVTX N/A
- Revenue Growth
- EIG 5.05
- TVTX 57.08
- 52 Week Low
- EIG $37.55
- TVTX $5.12
- 52 Week High
- EIG $54.44
- TVTX $20.33
- Technical
- Relative Strength Index (RSI)
- EIG 64.31
- TVTX 55.75
- Support Level
- EIG $51.99
- TVTX $16.86
- Resistance Level
- EIG $53.61
- TVTX $19.51
- Average True Range (ATR)
- EIG 0.94
- TVTX 1.05
- MACD
- EIG -0.00
- TVTX -0.16
- Stochastic Oscillator
- EIG 81.59
- TVTX 40.06
About EIG Employers Holdings Inc
Employers Holdings Inc provides workers' compensation insurance, to small businesses in low- to medium-hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through itswholly owned subsidiaries.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.